diagnostic value of serum level of soluble tumor necrosis factor receptor iiα in egyptian patients with chronic hepatitis c virus infection and hepatocellular carcinoma

conclusions serum stnfr-iiα could be used as a potential serum marker in diagnosing hcc among patients with hcv infection. results the serum level of stnfr-iiα was significantly higher in patients with hcc in comparison to the other groups. a positive correlation was found between the serum levels of stnfr-iiα and ast and alt in patients of group-ii. diagnosis of hcc among patients with hcv infection and cirrhosis could be ascertained when stnfr-iiα is assessed at a cutoff value of ≥ 250 pg/ml. objectives the aim of this study was to determine the value of serum soluble tumor necrosis factor (tnf) receptor-iiα (stnfr-iiα) in diagnosis of hcc in patients with chronic hepatitis c virus (hcv) infection. patients and methods the study was performed on 110 subjects who were classified into five groups. group i included 20 patients with chronic noncirrhotic hcv infection and persistently normal transaminases for ≥6 months. group ii included 20 patients with chronic noncirrhotic hcv infection and elevated transaminases. group iii included 20 patients with chronic hcv infection and liver cirrhosis. group iv included 20 patients with chronic hcv infection with liver cirrhosis and hcc. group v included 30 healthy age and sex-matched controls. medical history was taken from all participants and they underwent clinical examination and abdominal ultrasonography. in addition, the following laboratory tests were requested: liver function tests, complete blood count, hbsag, anti-hcvab, hcv-rna by qualitative pcr, and serum levels of α-fetoprotein (afp) and stnfr-iiα. background the prognosis of hepatocellular carcinoma (hcc) is unfavorable and needs serum markers that could detect it early to start therapy at a potentially curable phase.